Renaissance sells non-sterile topicals and generics businesses to Mylan for $950mm
- Contract Research, Toxicology Testing-CRO
- Topical Delivery
- Generic Drugs
- Drug Delivery
- Full Acquisition
- Payment Includes Stock
- Includes Earnout
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.